HHS Issues Guidelines on Naloxone Prescribing, FDA Advisory Boards Recommend Increased Naloxone Access
On Wednesday, the U.S. Department of Health and Human Services (HHS) issued guidance for health care providers and patients detailing how naloxone should be prescribed to all patients at risk for opioid-related complications, including overdose. HHS Assistant Secretary for Health and Senior Advisor for Opioid Policy Adm. Brett Giroir announced the updated guidance that reinforces…
Read More »